SSY Group Gains Approval for Key Drug Production

SSY Group (HK:2005) has released an update.

SSY Group Limited has received approval from China’s National Medical Products Administration for the production of its Compound Sodium Acetate and Glucose Injection, which is used for replenishing water and electrolytes. This development positions SSY Group among the first three manufacturers in China to be approved for this type of drug production, signaling a promising advancement in their pharmaceutical offerings.

For further insights into HK:2005 stock, check out TipRanks’ Stock Analysis page.